Page 15 - Crown Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: Jun 03, 2021     SAN DIEGO--(BUSINESS WIRE)-- Crown Biosciences Inc. (CrownBio), a JSR Life Sciences Company, today announced that they have entered into separate, yet complementary, portfolio license agreements with the ATCC and the U.S. Department of Health and Human Services, as represented by the National Cancer Institute (NCI) of the National Institute of Health (NIH). By entering into five-year agreements with these premier biomaterial resource providers, CrownBio clients will directly benefit from a priority status that will make cell lines more readily available with ...

This Animal Model market report depicts the global market scenario in terms of market size and revenue. Real time market condition and industry data i

CrownBio Acquires OcellO B.V. to Expand Its Preclinical In Vitro Drug Development Service Offerings Wednesday, May 5, 2021 6:55PM IST (1:25PM GMT) Acquisition augments CrownBio’s preclinical in vitro service platforms, adding high content imaging and advanced tumor organoid analytics to three-dimensional immuno-oncology drug assays   San Diego, United States:   Crown Bioscience (CrownBio), a JSR Life Sciences company and leader in preclinical services that help biopharmaceutical companies accelerate new drug development programs...

FactMR: Animal Model Market Driven by Developments in Pharmaceutical and CRISPR Genetic Research, Opines Fact.MR Leading research organizations are investing increasingly in the use of advanced animal models for CRISPR and microinjection applications for long-term growth opportunities. NEW YORK, NY / ACCESSWIRE / April 14, 2021 / Fact.MR: The global revenue of animal model market will register a steady rate of growth through 2031, following substantial impetus emerging from drug and vaccine development endeavors. Fact.MR's latest study provides key animal model market statistics and actionab...

Share this article Share this article ResearchAndMarkets.com's offering. The global in vivo toxicology market size is projected to reach USD 6.6 billion by 2025 from USD 5.0 billion in 2020, at a CAGR of 5.5% during the forecast period. Market growth is driven largely by the increasing pharmaceutical R&D activities, innovations in animal models, the development of exclusive in vivo toxicology tests, and the increasing demand for personalized medicine. By Product, the consumables segment accounted for the largest share of the in vivo toxicology market. The in vivo toxicology market is catego...